Science
Proprietary assets developed by the Group and available for licensing.
Proprietary assets developed by the Group and available for licensing.
Semi-synthetic, water-soluble polyene antifungal in development for inhaled use against severe fungal infections.
Development stage Phase I
We supply, co-develop and license protein-based ingredients and assets.
Long-term, specification-controlled supply of standard grades.
Tailor-made preparations, scaled from bench to industrial production.
In- and out-licensing of patented processes, ingredients and assets.
Enquiries on products, documentation, distribution and partnerships are handled by the relevant specialist team.
For job applications, see Careers.
A copy has been sent to your email address. A specialist will reply within two business days.
We use necessary cookies to run this site. With your consent we also use Leadinfo to recognise which companies visit us. You can change your choice at any time from Cookie settings at the bottom of every page. Read our cookie policy.
